SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-18-000126
Filing Date
2018-02-06
Accepted
2018-02-06 16:34:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 e617632_sc13d-at.htm SC 13D 45087
2 e617632_ex99-a.htm EX-99.A 68804
3 e617632_ex99-b.htm EX-99.B 25633
4 e617632_ex99-c.htm EX-99.C 19931
  Complete submission text file 0001193805-18-000126.txt   160809
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87471 | Film No.: 18578013
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Filed by) CIK: 0001727315 (see all company filings)

Type: SC 13D